ClinicalTrials.gg
WithdrawnNCT07461168CarESUpdated Nov 20, 2026

Penn State Emergency Medicine CarES: Care-partner Evaluation and Sourcing in the Emergency Department

An interventional study of Care Partner Support and Education Messaging in Dementia, Caregiver Stress and Caregiver Burden, sponsored by Milton S. Hershey Medical Center. Withdrawn at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Milton S. Hershey Medical Center · Not applicable, Interventional, and Supportive care

How we know

Why this study was withdrawn
Funding terminated
Updated Nov 20, 2026Now WithdrawnStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,051 studies in Dementia with a site in United States — 211 open to participants now, 276 under way, 15 of them phase 3. Dementia · United States.

Enrollment
830th of 846
0 · median 93
Started
2024
with 77 others
No phase
562 of 1,051
118 open now
Registered
993rd of 1,051
by date

Among the 1,051 studies in Dementia with a site in United States, this one is the 830th largest by enrollment of the 846 interventional ones that give a count, is one of 78 that started in 2024, is one of 562 with no phase, and was the 993rd registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

211 of the 1,051 studies in Dementia with a site in United States are open now. Recruiting first, the newest first:

206 more — sign in →

All 211 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,051 studies in Dementia with a site in United States, or all of them as a file.
02

Study summary

Care partners of people living with dementia often experience ongoing stress and unmet support needs. This study evaluates the feasibility of a low-intensity, supportive education and resource intervention for care partners who previously participated in an observational study.

Participants complete a baseline phone interview and a short stress journaling activity, followed by a six-week series of automated educational and supportive messages delivered by text message or email. Participants may also take part in an optional peer support focus group. The study examines caregiver stress, resilience, engagement with resources, and participant feedback to inform future caregiver support interventions.

Read the detailed description

Care partners of people living with dementia often experience high levels of stress, burden, and unmet support needs, particularly during transitions of care. Even after participating in prior observational research, caregiving demands and stressors may evolve over time, highlighting the need for ongoing education and support.

This is a mixed-methods, minimal-risk interventional study designed to evaluate the feasibility and utility of a low-intensity, supportive education and resource intervention for care partners of people living with dementia. Participants eligible for this study are care partners who previously completed an approved observational study conducted in the emergency department setting.

The study consists of three sequential phases. In the first phase, participants complete a baseline telephone interview assessing caregiver stress, burden, resilience, technology literacy, and caregiving experiences. Participants also complete a brief, structured stress journaling activity over a two-week period to document daily caregiving-related stressors.

In the second phase, participants receive a six-week series of automated educational and supportive messages delivered by text message or email. These messages provide dementia caregiving education, stress and grief management strategies, and links to publicly available caregiver resources. Brief check-in surveys are used to assess participant engagement, perceived usefulness of the materials, and caregiving stressors during this period.

In the final phase, participants are invited to attend an optional, in-person peer support focus group facilitated by trained study personnel. The focus group provides an opportunity for participants to share experiences, discuss caregiving needs, and provide qualitative feedback on the intervention. Sessions are audio recorded for qualitative analysis.

The primary goals of this continuation supplement are to assess the feasibility of delivering supportive educational resources to care partners using low-touch methods, evaluate changes in caregiver stress and resilience, and gather qualitative feedback to inform future caregiver support interventions.

03

Conditions studied

  • Dementia
  • Caregiver Stress
  • Caregiver Burden
  • Caregiver Burden of People With Dementia
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Person completed the CarES Observational Study.
  • Person is a care partner and:
  • Lives with the person living with dementia or
  • Checks on them at least once per week in person or by phone
  • Person is willing and able to participate in study assessments

Exclusion criteria

Exclusion Criteria:

  • Person is no longer a care partner for a person living with dementia
  • Person declines participation
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Care Partner Support and Education Intervention (Continuation Supplement)

    Participants receive a low-intensity, supportive intervention that includes a baseline phone interview, a short period of daily stress journaling, and a six-week series of automated educational and supportive messages delivered by text message or email. Messages provide dementia caregiving education, stress management strategies, and links to publicly available resources. Participants complete brief surveys to assess engagement, stress, and resilience and may participate in an optional peer support focus group to provide qualitative feedback on the intervention.

    Behavioral: Care Partner Support and Education Messaging

Interventions

  • BehavioralCare Partner Support and Education Messaging

    Care partners receive a low-intensity, supportive intervention consisting of automated educational and supportive messages delivered by text message (SMS) or email over a six-week period. Messages include brief dementia caregiving education, stress and grief management strategies, and links to publicly available caregiving and community support resources. Participants are asked to complete brief check-in surveys to assess engagement, perceived usefulness of the materials, and caregiving stressors.

06

What researchers measure

Primary outcomes

  1. Change in Care Partner Stress

    Caregiver stress will be assessed using the Stress Thermometer, scored from 0 (no stress/distress) to 4 (extreme stress/distress). Higher scores indicate greater stress (worse outcome).

    Time frame: Baseline (prior to intervention) to post-intervention (approximately 6 weeks).

  2. Change In Care Partner Burden

    Caregiver burden will be assessed using the 3-item Zarit Caregiver Burden Interview Screen, calculated as the sum of 3 items, each scored 0-4, for a total score range 0-12 (calculated from item scoring). Higher total scores indicate greater caregiver burden (worse outcome).

    Time frame: Baseline (prior to intervention) to post-intervention (approximately 6 weeks)

Secondary outcomes

  1. Care Partner Resilience (Brief Resilience Scale total score)

    Care partner resilience will be assessed using the Brief Resilience Scale (BRS). The Brief Resilience Scale total score will be calculated as the mean of 6 items rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Total scores range from 1 to 5, with higher scores indicating greater resilience (better outcome).

    Time frame: Baseline to post-intervention (approximately 6 weeks).

Other outcomes

  1. Engagement With Support Resources (check-in survey completion rate)

    Participant engagement will be assessed by the proportion of SMS/email check-in surveys completed during the intervention period. Engagement will be calculated as the number of completed check-in surveys divided by the number of surveys sent, expressed as a percentage (0-100%). Higher percentages indicate greater engagement with program communications and support resources.

    Time frame: During the 6-week intervention period

  2. Perceived usefulness of support resources

    Participant-reported usefulness of educational and supportive materials will be assessed using a self-reported usefulness rating collected through check-in surveys. Ratings will be reported on a Likert scale (e.g., 1-5), with higher scores indicating greater perceived usefulness of the materials.

    Time frame: During the 6-week intervention period

  3. Feasibility of the Support Intervention

    Feasibility assessed by participation rates, survey completion rates, and retention across intervention phases.

    Time frame: Up to 3 months

  4. Qualitative Care Partner Experiences and Feedback

    Qualitative themes related to caregiving experiences, perceived needs, and feedback on the intervention will be identified through semi-structured empathy-focused interviews and peer support focus groups conducted with care partners. Transcripts will be analyzed using qualitative thematic analysis to identify common experiences, perceived benefits, challenges, and suggestions for improving the intervention.

    Time frame: During the intervention period and within 2 weeks following completion of the 6-week intervention

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Feb 2024; primary completion for Aug 2026, 30 months later.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: start Aug 2026 → Feb 2024, primary completion Dec 2026 → Aug 2026 and completion Dec 2026 → Aug 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2025
First posted
Mar 10, 2026
StartEst.
Feb 1, 2024was Aug 2026
Primary completionEst.
Aug 14, 2026was Dec 2026
CompletionActual
Aug 14, 2026was Dec 2026
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Withdrawn Funding terminated
changed Nov 20, 2026
Start date
Aug 31, 2026→Feb 1, 2024
Nov 20, 2026
Primary completion
Dec 30, 2026→Aug 14, 2026
Nov 20, 2026
Study completion
Dec 30, 2026→Aug 14, 2026 (actual)
Nov 20, 2026
Enrollment
20 (estimated)→0 (actual)
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Not yet recruiting→Withdrawn
    Why stopped Funding terminated
    Start date Aug 31, 2026→Feb 1, 2024
    Primary completion Dec 30, 2026→Aug 14, 2026
    Study completion Dec 30, 2026→Aug 14, 2026 (now actual)
    Enrollment 20 (estimated)→0 (actual)
    + 1 other change: contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07461168
Responsible party
Michelle A. Fischer (Associate Professor, Emergency Medicine and Program Director, Emergency Medicine Residency, Milton S. Hershey Medical Center) — Principal investigator
First posted
Mar 10, 2026
Start date
Feb 1, 2024 (estimated)
Primary completion
Aug 14, 2026 (estimated)
Completion
Aug 14, 2026
Last update
Nov 20, 2026

Study contacts

Michelle Fischer, MD, MPH
principal investigator · Penn State College of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion